We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+8.96%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.08B
AUM Growth
+$407M
Cap. Flow
+$226M
Cap. Flow %
4.45%
Top 10 Hldgs %
23.59%
Holding
154
New
18
Increased
54
Reduced
21
Closed
16

Top Buys

Rank Stock Value
1
DOCS icon
Doximity
DOCS
+$69.6M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$63M
3
MDB icon
MongoDB
MDB
+$59.3M
4
DV icon
DoubleVerify
DV
+$47.6M
5
FLYW icon
Flywire
FLYW
+$39.8M

Top Sells

Rank Stock Value
1
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$165M
2
DUOL icon
Duolingo
DUOL
+$33.1M
3
KURA icon
Kura Oncology
KURA
+$32.8M
4
COGT icon
Cogent Biosciences
COGT
+$30.6M
5
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
+$25.8M

Sector Composition

Rank Sector Weight
1 Healthcare 38.81%
2 Technology 24%
3 Industrials 15.64%
4 Consumer Discretionary 5.21%
5 Utilities 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NARI
76
DELISTED
Inari Medical, Inc. Common Stock
NARI
$19.3M 0.38%
266,030
+204,330
+331% +$15.2M
IRTC icon
77
iRhythm Holdings
IRTC
$3.91B
$18.6M 0.37%
148,830
+119,530
+408% +$17.3M
WEC icon
78
WEC Energy
WEC
$35.9B
$18.2M 0.36%
203,400
+11,400
+6% +$1.16M
NTLA icon
79
Intellia Therapeutics
NTLA
$1.55B
$17.9M 0.35%
+319,000
New +$19.8M
FRC
80
DELISTED
First Republic Bank
FRC
$17.2M 0.34%
132,015
+5,615
+4% +$862K
KLAC icon
81
KLA
KLAC
$236B
$16.3M 0.32%
538,330
+98,050
+22% +$3.4M
SNPS icon
82
Synopsys
SNPS
$71.3B
$15.9M 0.31%
52,166
-3,991
-7% -$1.35M
ESI icon
83
Element Solutions
ESI
$8.68B
$15.8M 0.31%
971,000
– –
AESC
84
DELISTED
The AES Corporation
AESC
$15.1M 0.3%
171,200
+20,100
+13% +$1.86M
STRO icon
85
Sutro Biopharma
STRO
$411M
$15M 0.3%
270,898
– –
INSP icon
86
Inspire Medical Systems
INSP
$1.44B
$14.9M 0.29%
84,050
+61,150
+267% +$12.3M
NOVT icon
87
Novanta
NOVT
$4.95B
$14.6M 0.29%
125,900
-154,100
-55% -$21M
PNR icon
88
Pentair
PNR
$10.6B
$14.2M 0.28%
350,400
– –
MRTX
89
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$14.2M 0.28%
203,600
+90,600
+80% +$6.7M
PRVA icon
90
Privia Health
PRVA
$3.01B
$14.2M 0.28%
415,985
+138,185
+50% +$5.11M
CMS icon
91
CMS Energy
CMS
$22.7B
$14.1M 0.28%
242,158
-44,642
-16% -$3M
ISRG icon
92
Intuitive Surgical
ISRG
$126B
$14.1M 0.28%
75,000
– –
VECT
93
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
$14M 0.28%
2,339,044
– –
PRTA icon
94
Prothena Corp
PRTA
$440M
$13.9M 0.27%
+230,000
New +$7.27M
SHLS icon
95
Shoals Technologies Group
SHLS
$1.49B
$13.4M 0.26%
620,832
– –
BEAM icon
96
Beam Therapeutics
BEAM
$2.73B
$12.7M 0.25%
+267,025
New +$15.2M
RARE icon
97
Ultragenyx Pharmaceutical
RARE
$2.56B
$12.7M 0.25%
+305,800
New +$15.7M
ARVN icon
98
Arvinas
ARVN
$536M
$12.5M 0.25%
+281,500
New +$13.7M
SYY icon
99
Sysco
SYY
$40.6B
$12.5M 0.25%
177,100
+15,802
+10% +$1.32M
VCYT icon
100
Veracyte
VCYT
$4.77B
$12.2M 0.24%
732,000
+314,000
+75% +$7.07M
2 3
4
5 6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2022 Portfolio in Review

As of Q3 2022, Eventide Asset Management held 154 positions worth $5.08B, up 8.7% from $4.68B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management deployed $226M of net new capital in Q3 2022, opening 18 new positions and adding to 54 existing holdings. Its largest new stake was DoubleVerify: 1,847,144 shares worth $50.5M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Cogent Biosciences, an estimated $30.6M trimmed.

  • Eventide Asset Management's largest Q3 2022 buy was DoubleVerify: 1,847,144 shares worth $50.5M.
  • Eventide Asset Management added most to Doximity in Q3 2022, an estimated $69.6M increase.
  • Eventide Asset Management's biggest Q3 2022 reduction was Cogent Biosciences, cutting an estimated $30.6M.
  • Eventide Asset Management fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q3 2022, selling an estimated $165M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $5.08B portfolio in Q3 2022.
  • Eventide Asset Management opened 18 new positions and closed 16 in Q3 2022.
  • Eventide Asset Management's portfolio value rose 8.7% quarter-over-quarter to $5.08B.

Based on Eventide Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.